Markets:

Overview

News

Currencies

International

Treasuries

ResMed Inc. Common Stock (NY:RMD)

252.55 +6.82 (+2.78%)

Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

$100 Invested In ResMed 5 Years Ago Would Be Worth This Much Today ↗

March 17, 2023

Via Benzinga

ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum

March 15, 2023

From ResMed Inc.

Via GlobeNewswire

ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep

March 13, 2023

From ResMed Inc.

Via GlobeNewswire

ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference

March 07, 2023

From ResMed Inc.

Via GlobeNewswire

$100 Invested In ResMed 10 Years Ago Would Be Worth This Much Today ↗

February 08, 2023

Via Benzinga

Hopeful Golden Cross Forms On ResMed's Chart ↗

January 26, 2023

Via Benzinga

A Preview Of ResMed's Earnings ↗

January 25, 2023

Via Benzinga

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023

January 26, 2023

From ResMed Inc.

Via GlobeNewswire

ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus

January 26, 2023

From ResMed Inc.

Via GlobeNewswire

ResMed to Report Second Quarter Fiscal 2023 Earnings on January 26, 2023

January 12, 2023

From ResMed Inc.

Via GlobeNewswire

Where ResMed Stands With Analysts ↗

October 28, 2022

ResMed (NYSE:RMD) has observed the following analyst ratings within the last quarter:

Via Benzinga

Competitor Recall Continues To Show Opportunities For ResMed ↗

August 12, 2022

Via Benzinga

Earnings Scheduled For August 11, 2022 ↗

August 11, 2022

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

Via Benzinga

Earnings Scheduled For January 26, 2023 ↗

January 26, 2023

Companies Reporting Before The Bell • Nokia (NYSE:NOK) is estimated to report quarterly earnings at $0.14 per share on revenue of $7.20 billion.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023 ↗

January 17, 2023

Via Benzinga

ResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare Conference

January 02, 2023

From ResMed Inc.

Via GlobeNewswire

ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions

November 22, 2022

From ResMed Inc.

Via GlobeNewswire

Looking Into ResMed's Return On Capital Employed ↗

November 01, 2022

According to Benzinga Pro, during Q1, ResMed (NYSE:RMD) earned $210.48 million, a 7.9% increase from the preceding quarter. ResMed also posted a total of $950.29 million in sales, a 3.89% increase...

Via Benzinga

Company Report Roundup: Tesla, Tractor Supply, American Express, and More ↗

October 29, 2022

Plus a look at investing books, stocks to watch, and other topics for investors.

Via The Motley Fool

ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023

October 27, 2022

From ResMed Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022 ↗

October 20, 2022

Upgrades

Via Benzinga

Earnings Scheduled For October 27, 2022 ↗

October 27, 2022

Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million.

Via Benzinga

ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022

October 13, 2022

From ResMed Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022 ↗

October 12, 2022

Upgrades

Via Benzinga

Silk Road Medical Stock Scores Relative Strength Rating Upgrade ↗

September 28, 2022

Silk Road Medical sees its Relative Strength Rating reach the elite 90-plus level.

Via Investor's Business Daily

Hopeful Golden Cross Forms On ResMed's Chart ↗

September 22, 2022

If history is any guide, there may be good fortune ahead for shares of ResMed (NYSE:RMD). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Via Benzinga

Tuesday Is Your Last Chance To Buy ResMed Before The Dividend Payout ↗

August 12, 2022

Tuesday marks the last chance for investors to receive the next dividend payout from ResMed (NYSE:RMD).

Via Benzinga

$100 Invested In This Stock 20 Years Ago Would Be Worth $3,400 Today ↗

August 03, 2022

ResMed (NYSE:RMD) has outperformed the market over the past 20 years by 11.43% on an annualized basis producing an average annual return of 19.33%. Currently, ResMed has a market capitalization of...

Via Benzinga

How Is The Market Feeling About ResMed? ↗

July 25, 2022

ResMed's (NYSE:RMD) short percent of float has fallen 6.8% since its last report. The company recently reported that it has 1.39 million shares sold short, which is 0.96% of all...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022 ↗

August 12, 2022

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

ResMed Inc. Common Stock (NY:RMD)

All News about ResMed Inc. Common Stock

Starting at $3.75/week.

Subscribe Today